Here are four recent news updates on gastroenterology and endoscopy companies.
Zacks Investment Research noted EndoChoice has been assigned a consensus broker rating score of 1.00 — strong buy — from the four brokers that provide coverage for the company.
Following CMS' decision to maintain Medicare reimbursement for Cologuard, Exact Sciences' shares rose 6.8 percent, according to a Journal Sentinel report.
Modernizing Medicine completed the previously announced acquisition of gMed.
The American Gastroenterological Association, Crohn's & Colitis Foundation of America and Janssen Biotech selected Theresa Alenghat, VMD, PhD as the inaugural winner of the 2015 AGA-CCFA-Janssen Research Award in Inflammatory Bowel Disease Epigenetics Research.
If you have a question, issue or note to suggest on a GI/endoscopy company please contact Carrie Pallardy at firstname.lastname@example.org.